Related Experiment Videos
Interaction between tissue transglutaminase and phospholipid vesicles
FEBS Letters
|May 2, 1983
Summary
Liver transglutaminase interacts with phospholipid vesicles during lipid phase transitions, releasing encapsulated molecules. This enzyme-phospholipid interaction is specific and reduces enzyme activity.
Area of Science:
- Biochemistry
- Membrane Biophysics
- Enzymology
Background:
- Phospholipid vesicles are model systems for cell membranes.
- Transglutaminases are enzymes involved in protein cross-linking.
- Enzyme-membrane interactions are crucial for cellular processes.
Purpose of the Study:
- To investigate the interaction between liver transglutaminase and phospholipid vesicles.
- To determine the conditions under which this interaction occurs.
- To understand the effect of the interaction on enzyme activity and vesicle integrity.
Main Methods:
- Small unilamellar phospholipid vesicles were prepared.
- Purified liver transglutaminase was incubated with vesicles.
- Carboxyfluorescein release assay was used to measure encapsulation.
- Sepharose 4B chromatography was employed to analyze enzyme-vesicle complexes.
- Enzyme activity assays were performed.
Main Results:
- A specific interaction between liver transglutaminase and phospholipid vesicles was observed at the lipid phase transition.
- Enzyme-induced bilayer perturbation led to the release of encapsulated carboxyfluorescein.
- The size of enzyme-phospholipid complexes varied with the protein-phospholipid ratio.
- Transglutaminase activity was significantly reduced upon insertion into the vesicle bilayer.
- Interaction was dependent on the vesicle's lipid phase and the enzyme's structural integrity.
Conclusions:
- Liver transglutaminase interacts specifically with phospholipid bilayers at their phase transition.
- This interaction perturbs the membrane, causing release of encapsulated contents.
- The enzyme's activity is diminished when integrated into the lipid bilayer.
- The findings provide insights into enzyme-membrane dynamics and potential mechanisms of drug delivery or membrane modification.